• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

    • Radiology
      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Treatment Resistant Depression Market Size to Worth US$ 1,545.6 Mn, with CAGR Value at a 3.4% by 2030 | AbbVie, Lupin, Eli Lilly and Company, GlaxoSmithKline

December 1st, 2022 Coherent Market Insights Releases

Overview:

Depression is a serious medical illness that affects a person’s mental, emotional and physical well-being. The patient feels a loss of interest and has a feeling of sadness. Many people have trouble doing daily activities. Hs can also cause various physical an emotional problems. Several drugs are used for treating depression like antidepressants. These drugs help in relieving the symptoms of anxiety disorders, seasonal affective disorder and social anxiety disorder.

Global treatment resistant depression market, is forecast to be valued at US$ 1,180.0 Mn in 2022 and is estimated to exhibit a CAGR of 3.4% during the forecast period.

Request FREE Sample Report (Including Full TOC, Table & Figures) @
https://www.coherentmarketinsights.com/insight/request-sample/5196

Impact of COVID-19:

COVID-19 was initially reported in China, in December, 2019. On March 11, 2020, the World Health Organization declared this as a pandemic and the Epidemiological Update, for Coronavirus by the WHO mentioned that till June 6, 2022, almost 532 million cases of COVID-19 were reported and it also caused 6 million deaths globally.

The pandemic also affected many clinical trial on various drugs that were used for depression by several research institutes, this had a negative impact on many research and development activities being carried out on new drugs worldwide. For instance,

Medidata technology and solutions, conducted electronic survey on 9,952 of their staff members on April 23, 2020, at several trial sites worldwide. This survey showed a response rate of 10.3%, and out of 1,030 participants only a few answered the survey. 58.3% respondents of the survey belonged to the U.S. (North America), 23.8% were from Asia Pacific, which was followed by Europe with 8.1%, 7.1% were from South & Central America and Middle East & Africa accounted for 2.7%. Investigators, clinical nurses, study coordinators and site managers were a part of the study. This survey also showed that COVID-19 had affected the ability to carry out clinical trials and also impacted starting of new trials.

Drivers:

Rising prevalence of depression is estimated to propel growth of global treatment resistant depression market over the forecast period. For instance, the Journal of Clinical Psychiatry published an article in 2021, stating that 8.9 million individuals were treated with major depressive disorder and almost 2.8 million individuals had treatment-resistant depression in the U.S.

Furthermore, rising launches of generic products by major players is estimated to augment growth of the global treatment resistant depression market over the forecast period. For instance, Dr. Reddy’s Laboratories Ltd. declared the launch of Bupropion Hydrochloride Extended-Release Tablets in September 2019. These are generic version of Zyban Extended-Release Tablets, which have been approve by the U.S. FDA.

Download PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/5196

Key Takeaways:

Global treatment resistant depression market is estimated to exhibit a CAGR of 3.4% during the forecast period, due to the rising incidences of treatment-resistant depression. For instance, Frontiers Media S.A, published an article on 2 March 2022, stating the prevalence of treatment-resistant depression was 21% in Mexico, 32% was reported in Colombia, Argentina reported 33%, and 40% in Brazil.

Key Players:

Key players active in the global treatment resistant depression market are Aurobindo Pharma Ltd, AbbVie Inc., AstraZeneca, Lupin, H. Lundbeck A/S, Eli Lilly and Company, Otsuka Holdings Co., Ltd., GlaxoSmithKline Plc., Viatris Inc., Pfizer Inc., Merck & Co., Inc., Bausch Health Companies Inc., Johnson & Johnson and Sanofi, Mallinckrodt.

Reasons to buy this Treatment Resistant Depression Market Report

☑ It attempts an analysis of the competing scenario.

☑ The current and exceptional product revenue market.

☑ An in-depth data on the regional investigation and competitive landscape structure.

☑ It benefits in creating an awareness of the important key product segments.

☑ The marketing strategies, opportunities, and development factors are explained.

☑ Treatment Resistant Depression market size estimation and recent advancements in the industry are explained.

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5196

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Treatment Resistant Depression Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Treatment Resistant Depression Industry Impact

Chapter 2 Global Treatment Resistant Depression Competition by Types, Applications, and Top Regions and Countries
2.1 Global Treatment Resistant Depression (Volume and Value) by Type
2.3 Global Treatment Resistant Depression (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Treatment Resistant Depression Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Treatment Resistant Depression Market Analysis
Chapter 6 East Asia Treatment Resistant Depression Market Analysis
Chapter 7 Europe Treatment Resistant Depression Market Analysis
Chapter 8 South Asia Treatment Resistant Depression Market Analysis
Chapter 9 Southeast Asia Treatment Resistant Depression Market Analysis
Chapter 10 Middle East Treatment Resistant Depression Market Analysis
Chapter 11 Africa Treatment Resistant Depression Market Analysis
Chapter 12 Oceania Treatment Resistant Depression Market Analysis
Chapter 13 South America Treatment Resistant Depression Market Analysis
Chapter 14 Company Profiles and Key Figures in Treatment Resistant Depression Business
Chapter 15 Global Treatment Resistant Depression Market Forecast (2022-2028)
Chapter 16 Conclusions

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact us:

Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email